AzTrials
AzTrials

Herniated DiscNCT07036445

Comparison of Interlaminar CT Guided Epidural Platelet Rich Plasma Versus Steroid Injection in Patients With Lumbar Radicular Pain

A study testing Epidural Steroid Injection and Epidural platelet-rich plasma injection in people with Herniated Disc, run by Clinique du Sport, Bordeaux Mérignac at 1 site in France.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The treatment of persistent lumbar radicular pain (LRP) using CT-guided epidural steroid injection (ESI) is widely used and associated with rare but serious complications. Platelet-rich plasma (PRP), which has recently been shown to promote healing and the anti-inflammatory process by delivering growth factors and… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Herniated Disc
What is being tested?
Epidural Steroid Injection and Epidural platelet-rich plasma injection
Could I receive a placebo?
No, everyone receives an active treatment
How many people
200 participants
Where
1 siteFrance
Study dates
11 Sep 2025to 31 Dec 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Diagnosis of unilateral resistant LRP associated with a herniated disc on MRI images. (Diagnosis of resistance after 6 weeks of appropriate medical treatment).

Who cannot join

  • Patients with infections,
  • Patients who have had previous percutaneous corticosteroid injections,
  • Patients undergoing systemic corticosteroid treatment,
  • Patients with immune deficiencies,
  • Patients who are allergic to the contrast medium used,
  • Pregnant or breastfeeding patients,
Show all 9Show fewer
  • Patients with a history of allergies to anesthetics or corticosteroids,
  • Anticoagulant treatment or blood disorders, patients on antiplatelet therapy
  • Taking NSAIDs within two weeks prior to the procedure

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

France1 site, 1 recruiting
  • Clinique du Sport

    Mérignac, 33700

    Marion Mandon, PhD, +33 (0)6 78 27 76 72, mmandon@vivalto-sante.com

    Recruiting

Other trials in France

About this study

Official title: Comparison of Interlaminar CT Guided Epidural Platelet Rich Plasma Versus Steroid Injection in Patients With Lumbar Radicular Pain : a Prospective Study With Long Term Follow up

The treatment of persistent lumbar radicular pain (LRP) using CT-guided epidural steroid injection (ESI) is widely used and associated with rare but serious complications. Platelet-rich plasma (PRP), which has recently been shown to promote healing and the anti-inflammatory process by delivering growth factors and cytokines, could be an alternative and potentially safer option. A previous study showed that PRP was as effective as ESI in treating this condition, without major complications.

This study aims to compare these two treatments over the long term (2 years).

Conditions
Herniated Disc
Being tested
Epidural Steroid Injection, Epidural platelet-rich plasma injection
Medical subject headings
Intervertebral Disc Displacement

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Epidural Steroid InjectionProcedure or surgery

    Intervention consists of interlaminar CT guided epidural steroid injection

  • Epidural platelet-rich plasma injectionProcedure or surgery

    Intervention consists of interlaminar CT guided epidural platelet-rich plasma injection after recovery of plasma by blood sampling and centrifugation

Study groups in NCT07036445
Study groupRoleWhat they receive
steroid treatmentActive comparatorNot described
Receives: Procedure: Epidural Steroid Injection
platelet-rich plasma treatmentExperimentalNot described
Receives: Procedure: Epidural platelet-rich plasma injection

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Functional ability

    Oswestry Disability Questionnaire ranging from 0 to 100%

    Measured: 30 minutes before procedure ; 6 weeks after procedure ; 6 months, 1 year, 2 years after procedure

Secondary outcomes (1)
  1. Pain evaluation

    Numerical pain rating scale (NRS): intensity of combined pain in the legs and back ranging from 0 to 10

    Measured: 6 weeks, 6 months, 1 year and 2 years after procedure

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Jun 2025
  2. Study start11 Sep 2025
  3. Primary completion31 Dec 2028 (estimated)
  4. Study completion31 Dec 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
200 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07036445
Sponsor's protocol ID
2024-38-SBM
Status last verified
Sep 2025
First submitted
17 Jun 2025
Last updated
18 Sep 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Epidural Steroid Injection and Epidural platelet-rich plasma injection in people with Herniated Disc, run by Clinique du Sport, Bordeaux Mérignac at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 18 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Functional ability (time frame: 30 minutes before procedure ; 6 weeks after procedure ; 6 months, 1 year, 2 years after procedure). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Sep 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in